Takara Bio Usa Retronectin Gmp Grade Reagents Tender

• Country: USA
• Summary: Takara Bio Usa Retronectin Gmp Grade Reagents
• UST Ref No: 140775744
• Deadline: 14 May 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 26-005759
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Title:
  Takara Bio USA - RetroNectin® GMP Grade Reagents
  Product Service Code (PSC): 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
  NAICS Code: 325413 - In Vitro Diagnostic Substance Manufacturing
  Place of Performance:
  National Institutes of Health
  Clinical Center
  Bethesda, MD 20892
  POTS: 26-005759
  Description
  This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued, and quotations will not be requested.
  The National Institutes of Health (NIH), Clinical Center, intends to award a sole source firm-fixed-price contract to Takara Bio USA Inc. for the procurement of RetroNectin® GMP grade reagents.
  The requirement consists of 15 vials of RetroNectin® GMP grade reagent (Product Code: T202), which are critical for the manufacturing of cellular therapy products within the Center for Cellular Engineering (CCE).
  Background
  The Center for Cellular Engineering (CCE) supports over 50 intramural clinical trials and manufactures cellular therapy products used in patient care.
  Rationale:
  Takara Bio USA Inc. is the sole manufacturer of RetroNectin® GMP grade reagent. Substitution is not permissible without revalidation and regulatory approval, which could delay treatment and pose risks to patient care
  Authority
  This acquisition is being conducted in accordance with:
  FAR 13.106-1(b)(1) - Soliciting from a Single Source
  Under this authority, the Contracting Officer may solicit from a single source when it is determined that only one source is reasonably available to meet the Government-s requirements.
  Acquisitions conducted under FAR Part 13 - Simplified Acquisition Procedures are exempt from the competition requirements of FAR Part 6.
  Responses
  This is not a request for quotations. However, interested parties may submit a capability statement demonstrating their ability to meet the Government-s requirement.
  Respo...
• Documents:

 Tender Notice